71 Peginterferon Alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and caucasian patients with chronic hepatitis C virus genotype 1: results of a multicenter study

Caucasian Patients ◽

307 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C virus genotype 1 infection: Assessment of histologic response

Hepatology ◽

10.1016/s0270-9139(03)80350-6 ◽

2003 ◽

Vol 38 ◽

pp. 303-303 ◽

Cited By ~ 1

Author(s):

W CASSIDY ◽

L JEFFERS ◽

C HOWELL ◽

K RAJENDERREDDY ◽

S SHERIDAN ◽

...

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Histologic Response ◽

Caucasian Patients ◽

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2011.01515.x ◽

2011 ◽

Vol 19 (2) ◽

pp. e120-e125 ◽

Cited By ~ 3

Author(s):

A. Craxi ◽

S. Koutsounas ◽

P. Ogurtsov ◽

L. Chemello ◽

M. Maticic ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Viral Load ◽

Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Viral Response ◽

Rapid Viral Response ◽

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial

Hepatology ◽

10.1002/hep.26386 ◽

2013 ◽

Vol 57 (6) ◽

pp. 2155-2163 ◽

Cited By ~ 53

Author(s):

Mark S. Sulkowski ◽

Marc Bourlière ◽

Jean-Pierre Bronowicki ◽

Tarik Asselah ◽

Jean-Michel Pawlotsky ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

IL28B genetic variation and ratio of y-GT/ALT as predictors for virological response in chronic hepatitis C virus genotype 1 infected patients

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1295892 ◽

2012 ◽

Vol 50 (01) ◽

Author(s):

A Amanzada ◽

S Schneider ◽

F Moriconi ◽

M Blaschke ◽

T Suermann ◽

...

Keyword(s):

Genetic Variation ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Genotype 1 ◽

Virus Genotype ◽

Faculty Opinions recommendation of Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718061915.793484659 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Dose Reduction ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Head-to-head clinical Trial of Sofosbuvir plus Daclatasvir or Simeprevir for 12 weeks in Non-cirrhotic subjects with significant fibrosis infected with chronic Hepatitis C Virus genoType 1 (TNT-1 Study)

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2018.04.4264 ◽

2018 ◽

Vol 73 ◽

pp. 376

Author(s):

H. Pott Junior ◽

G. Bricks ◽

G. Grandi ◽

J. Senise ◽

A. Castelo

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Significant Fibrosis ◽

Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

Journal of Viral Hepatitis ◽

10.1111/jvh.13159 ◽

2019 ◽

Vol 26 (10) ◽

pp. 1229-1232

Author(s):

Tarik Asselah ◽

Stephen D. Shafran ◽

Stefan Bourgeois ◽

Ching‐Lung Lai ◽

Philippe Mathurin ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Fixed Dose ◽

Genotype 1 ◽

Virus Genotype ◽

Deferred Treatment ◽

Dose Combination

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

Hepatology ◽

10.1002/hep.27890 ◽

2015 ◽

Vol 62 (1) ◽

pp. 25-30 ◽

Cited By ~ 69

Author(s):

Saleh A. Alqahtani ◽

Nezam Afdhal ◽

Stefan Zeuzem ◽

Stuart C. Gordon ◽

Alessandra Mangia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Iii ◽

Genotype 1 ◽

Virus Genotype ◽

EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis

Journal of Hepatology ◽

10.1016/s0168-8278(17)30269-6 ◽

2017 ◽

Vol 66 (1) ◽

pp. S3-S4 ◽

Cited By ~ 7

Author(s):

X. Forns ◽

S. Lee ◽

J. Valdes ◽

S. Lens ◽

R. Ghalib ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Genotype 1 ◽

Virus Genotype ◽

Compensated Cirrhosis ◽

GS‐9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double‐blind, dose‐ranging phase 1 study

Journal of Viral Hepatitis ◽

10.1111/jvh.12527 ◽

2016 ◽

Vol 23 (8) ◽

pp. 614-622 ◽

Cited By ~ 41

Author(s):

M. Rodriguez‐Torres ◽

S. Glass ◽

J. Hill ◽

B. Freilich ◽

D. Hassman ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Phase 1 ◽

Genotype 1 ◽

Virus Genotype ◽

Phase 1 Study ◽

Double Blind ◽

Dose Ranging